Ardelyx, Inc. - stock earnings
ARDX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | -0.11 / -0.15 | - | 46.0 million / 36.5 million | - |
ARDX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -28.8 million USD | 34.4 million USD |
| 2023Q3 | 6.6 million USD | 56.4 million USD |
| 2023Q2 | -17.1 million USD | 22.3 million USD |
| 2023Q1 | -26.8 million USD | 11.4 million USD |
| 2022Q4 | 10.7 million USD | 44.2 million USD |
| 2022Q3 | -23.9 million USD | 5.0 million USD |
| 2022Q2 | -26.9 million USD | 2.5 million USD |
| 2022Q1 | -28.1 million USD | 468000 USD |
| 2021Q4 | -36.2 million USD | 1.0 million USD |
| 2021Q3 | -43.6 million USD | 1.2 million USD |
| 2021Q2 | -45.2 million USD | 1.3 million USD |
| 2021Q1 | -33.2 million USD | 6.6 million USD |
| 2020Q4 | -28.9 million USD | 1.8 million USD |
| 2020Q3 | -18.1 million USD | 2.7 million USD |
| 2020Q2 | -25.0 million USD | 1.8 million USD |
| 2020Q1 | -22.4 million USD | 1.2 million USD |
| 2019Q4 | -19.8 million USD | 2.3 million USD |
| 2019Q3 | -23.5 million USD | 3.0 million USD |
| 2019Q2 | -25.5 million USD | 18000 USD |
| 2019Q1 | -26.1 million USD | 85000 USD |
| 2018Q4 | -27.9 million USD | 85000 USD |
| 2018Q3 | -24.1 million USD | 172000 USD |
| 2018Q2 | -22.3 million USD | 30000 USD |
| 2018Q1 | -17.0 million USD | 2.3 million USD |
| 2017Q4 | 10.1 million USD | 42.0 million USD |
| 2017Q3 | -20.7 million USD | ? USD |
| 2017Q2 | -25.7 million USD | ? USD |
| 2017Q1 | -28.0 million USD | ? USD |
| 2016Q4 | -31.3 million USD | ? USD |
| 2016Q3 | -29.0 million USD | ? USD |
| 2016Q2 | -28.6 million USD | ? USD |
| 2016Q1 | -23.5 million USD | ? USD |
| 2015Q4 | -17.0 million USD | 24.0 million USD |
| 2015Q3 | -18.1 million USD | 18.1 million USD |
| 2015Q2 | 9.0 million USD | 18.1 million USD |
| 2015Q1 | -3.5 million USD | 5.9 million USD |
| 2014Q4 | -4.0 million USD | 6.3 million USD |
| 2014Q3 | 74000 USD | 7.6 million USD |
| 2014Q2 | 3.8 million USD | 9.1 million USD |
| 2014Q1 | -3.1 million USD | 8.6 million USD |
| 2013Q4 | -4.3 million USD | 8.5 million USD |
| 2013Q3 | -934000 USD | 6.6 million USD |
| 2013Q2 | -891000 USD | 7.3 million USD |
| 2013Q1 | -470000 USD | 6.6 million USD |
| 2012Q4 | ? USD | 5.4 million USD |
ARDX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -66.1 million USD | 124.5 million USD |
| 2022 | -67.2 million USD | 52.2 million USD |
| 2021 | -158.2 million USD | 10.1 million USD |
| 2020 | -94.3 million USD | 7.6 million USD |
| 2019 | -94.9 million USD | 5.3 million USD |
| 2018 | -91.3 million USD | 2.6 million USD |
| 2017 | -64.3 million USD | 42.0 million USD |
| 2016 | -112.4 million USD | 24.0 million USD |
| 2015 | -29.6 million USD | 24.0 million USD |
| 2014 | -3.2 million USD | 31.6 million USD |
| 2013 | -6.6 million USD | 28.9 million USD |
| 2012 | -9.8 million USD | 5.4 million USD |
ARDX
Price: $8.72
52 week price:
Earnings Per Share: -0.30 USD
P/E Ratio: -148.17
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 8.1 million
Ebitda: -20.5 millionMarket Capitalization: 1.6 billion